Osprey Technology Acquisition Corp. (SFTW.U), announced the pricing of their upsized $275 million SPAC IPO this evening and the units are expected to begin trading tomorrow, Friday, November 1st, under the symbol NYSE: SFTW.U.
Osprey Technology will be focusing on companies in the technology sector and in particular, Software-as-a-Service companies (SaaS), and will be led by the Co-Chairmen team of Edward and Jonathan Cohen, and David DiDomenico, as Chief Executive Officer, President and Director.
Total SPAC deal count for 2019 year-to-date is now 45 with $10.83 billion in gross proceeds raised. The offering is anticipated to close on Tuesday, November 5, 2019.
Congratulations to all.
Credit Suisse acted as sole book-running manager for the offering and I-Bankers Securities, Inc. acted as co-manager. Ledgewood and Skadden, Arps, Slate, Meagher & Flom LLP, were Issuer’s Counsel and Underwriter’s Counsel, respectively.
Yorkville Acquisition Corp. (NASDAQ:YORKU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “YORKU”, Friday, June 27, 2025. The new SPAC plans to combine with a target company in the telecom, media or technology sectors. Yorkville Acquisition Corp.’s management team is led...
At the SPAC of Dawn As pressure on Fed Chairman Jerome Powell increases, the market is set to ingest a raft of new indicators today as well as hear from Cleveland Fed President Beth Hammack on the potential interest rate path. Today will also see June’s 8th SPAC IPO as Cantor Equity Partners III Inc....
Cantor Equity Partners III Inc. (NASDAQ:CAEP) announced the pricing of its upsized $240 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “CAEP”, Thursday, June 26, 2025. The new SPAC plans to combine with a target company in an industry where its management has relevant expertise such financial...
Launch One (NASDAQ:LPAA) has entered into a definitive agreement to combine with biotech firm Minovia Therapeutics at a $180 million pre-money valuation. Haifa, Israel-based Minovia is developing a drug platform based on mitochondrial cell therapies to potentially treat rare disorders as well as the effects of aging and other causes of bodily degeneration. The combined...
CEO Marc Nemati and Colombier II’s Omeed Malik break down the deal and the strategy. Despite its moniker as the “the everything store” you can’t buy everything on Amazon, and firearms are one of those things. But, GrabAGun has spent years building a platform for regulated online firearms purchases, and soon, consumers will be able...